Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elafin for myocardial protection during coronary artery bypass surgery
ISRCTN82061264Phase 2Completed
- Sponsor
- NHS Lothian
- Start
- Mar 2011
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 2, randomised trial in myocardial ischemia-reperfusion injury and Myocardial injury comparing Elafin with Placebo (2 arms). Primary endpoint: Area under the curve for plasma troponin I concentration over 48 hours. Started Mar 2011; status: completed.
02
Drugs
tiprelestat
03
Conditions
myocardial ischemia-reperfusion injuryMyocardial injury
Beyond the preview
Go deeper on ISRCTN82061264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN82061264.